According to the most recent financial data from April 2025, the EPS for the trailing twelve months is $2.08. Cooper Companies's EPS for 2024 amounted to $1.97, marking an increase from $1.49 in 2023. During the quarterly period ending on Apr 30, 2025, COO's EPS stood at $0.44.
Cooper Companies had an annual EPS of $1.97, indicating an increase of 32.2% from $1.49 in 2023. The quarterly per-share earnings for the period ending Apr 30, 2025, was $0.44, indicating a 2.2% decrease from the same quarter last year. COO's 12-month EPS stands at $2.08 as of April 2025. Cooper Companies's annual EPS in 2023 stood at $1.49, a 23.6% decrease year-over-year.
During the last 12 months, Cooper Companies has seen an EPS growth of -2.2% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -49.1% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of -3.5%. A 10-year view shows that COO has seen an average EPS growth of 3.5% per year.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
UTMD Utah Medical Products Inc | 15.49 | -13.5% | -0.7% | 0% |
NVS Novartis AG | 17.03 | -17.2% | -17.9% | 2.9% |
JNJ Johnson & Johnson | 17.89 | -57.9% | -9.7% | 0.4% |
COO Cooper Companies Inc | 35.86 | 32.2% | -49.1% | -3.5% |
TFX Teleflex Inc | 35.95 | -80.3% | -47.6% | -31.7% |
BSX Boston Scientific Corp | 76.91 | 16.7% | 22.2% | -17.9% |
All data is based on quarterly TTM periods, unless otherwise specified.